Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00054158
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 24
Not applicableEnded earlyNCT01962636
What this trial is testing

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Chronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 200
Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Early research (Phase 1)Active Not RecruitingNCT02909036
What this trial is testing

Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.

Who this might be right for
Multiple MyelomaAmyloidosis
Memorial Sloan Kettering Cancer Center 46
Very early researchUnknownNCT05850611
What this trial is testing

The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer

Who this might be right for
Diabetic Foot UlcersDiabetic Wound
Mashhad University of Medical Sciences 20
Not applicableNot Yet RecruitingNCT07564128
What this trial is testing

Infection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in Italy

Who this might be right for
Multiple Mieloma
Gruppo Italiano Malattie EMatologiche dell'Adulto 50
Not applicableStudy completedNCT02474563
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Korea, Ltd., Korea 171
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT00083681
What this trial is testing

DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse

Who this might be right for
Multiple Myeloma
University of Arkansas 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT02773030
What this trial is testing

Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 466
Large-scale testing (Phase 3)Study completedNCT00713193
What this trial is testing

Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Ohio State University 26
Early research (Phase 1)Study completedNCT03828292
What this trial is testing

An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 15
Not applicableStudy completedNCT03638232
What this trial is testing

Myeloma Treatment in Real Life

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 236
Large-scale testing (Phase 3)Study completedNCT00719563
What this trial is testing

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+7 more
Alliance for Clinical Trials in Oncology 364
Not applicableStudy completedNCT00112593
What this trial is testing

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more
Fred Hutchinson Cancer Center 5
Not applicableUnknownNCT04008888
What this trial is testing

A Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaPlasma Cell LeukemiaExtramedullary Plasmacytoma+6 more
Institute of Hematology & Blood Diseases Hospital, China 50
Very early researchStudy completedNCT04355897
What this trial is testing

CoVID-19 Plasma in Treatment of COVID-19 Patients

Who this might be right for
COVID 19
The Christ Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00027560
What this trial is testing

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07464210
What this trial is testing

Nemtabrutinib, Bortezomib, and Rituximab for WM

Who this might be right for
Waldenstrom Macroglobulinemia
Seoul National University Hospital 19
Early research (Phase 1)Study completedNCT00963820
What this trial is testing

Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 60
Next Page